Search results
Results From The WOW.Com Content Network
Integrative psychotherapy is the integration of elements from different schools of psychotherapy in the treatment of a client. Integrative psychotherapy may also refer to the psychotherapeutic process of integrating the personality : uniting the "affective, cognitive, behavioral, and physiological systems within a person".
Patrick Soon-Shiong (born July 29, 1952) is a South African and American businessman, investor, medical researcher, and transplant surgeon. He is the inventor of the drug Abraxane, which is used for lung, breast, and pancreatic cancer.
Enzyvant Therapeutics, which is focused on developing therapies for rare enzyme deficiencies [39] Myovant Sciences, founded in partnership with Takeda Pharmaceutical Company to develop medicines for women's health and prostate cancer [40] Spirovant, which focused on developing gene therapies for cystic fibrosis. [41]
In November 2015, the company announced it would collaborate with Heptares Therapeutics with its work on small-molecule calcitonin gene-related peptide antagonists for migraine treatment, with the deal generating up to $410 million. [46] Teva Active Pharmaceutical Ingredients (TAPI) operates within Teva as a stand-alone business unit. In 2009 ...
Shire's next acquisition didn't come until 2005 when it acquired Transkaryotic Therapeutics [10] and two years later – in 2007 – New River Pharmaceuticals Inc, for a then company record of $2.6 billion. [11] With the purchase of New River, Shire gained access and ownership of Vyvanse.
2012 – Mallinckrodt announced acquisition of CNS Therapeutics for $100 million [66] 2013 – Mallinckrodt spun off from Covidien and began trading under ticker symbol MNK [ 2 ] 2013 – Mallinckrodt acquired Cadence Pharmaceuticals for £1.3 billion in an Irish corporate tax inversion to escape U.S. taxes.
Intellia Therapeutics, Inc. is an American clinical-stage biotechnology company focused on developing novel, potentially curative therapeutics leveraging CRISPR-based technologies. The company's in vivo programs use intravenously administered CRISPR as the therapy, in which the company's proprietary delivery technology enables highly precise ...
Arcturus Therapeutics Holdings Inc. is an American RNA medicines biotechnology company focused on the discovery, ...